Ibex secures $55m. in funding to advance AI-powered cancer diagnostics
Ibex Medical Analytics, a key player in the field of AI-driven cancer diagnostics, has successfully closed a $55 million Series C funding round, the company announced on Wednesday. The round was led by 83North, with participation from Sienna Venture Capital and existing investors, including Octopus Ventures, aMoon, Planven Entrepreneur Ventures, and Dell Technologies Capital. With […]
Continue Reading